Drug Profile
Adapalene/benzoyl peroxide - Sol-Gel
Alternative Names: ADUO; Benzoyl-peroxide/adapalene - Sol-GelLatest Information Update: 30 Aug 2023
Price :
$50
*
At a glance
- Originator Sol-Gel Technologies
- Class Anti-infectives; Anti-inflammatories; Antiacnes; Benzoic acids; Keratolytics; Naphthalenes; Oxidants; Retinoids; Small molecules
- Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne vulgaris
Most Recent Events
- 30 Aug 2023 Discontinued - Preclinical for Acne vulgaris in Israel (Topical) (Sol-Gel Technologies pipeline, August 2023)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Acne-vulgaris in Israel (Topical, Cream)
- 16 Feb 2016 Preclinical trials in Acne vulgaris in Israel (Topical) prior to February 2016 (Sol-Gel Technologies pipeline, February 2016)